Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2001-5-17
pubmed:abstractText
Compounds that inhibit aromatase activity are used for the treatment of breast cancer. A group of sesquiterpene lactones inhibit aromatase activity and also exert cytotoxicity through their reactive alpha-methylene-gamma-lactone group. To synthesize sesquiterpene lactones with greater specificity for aromatase inhibition and lower cytotoxicity, we chemically reduced the alpha-methylene-gamma-lactone group in the active aromatase inhibitor 10-epi-8-deoxycumambrin B (compound 1), to obtain the new compound 11betaH,13-dihydro-10-epi-8-deoxycumambrin B (compound 2). Reduction of the alpha-methylene-gamma-lactone group abrogated the cytotoxic activity of compound 1 against the JEG-3, HeLa, and COS-7 cell lines. Compound 2 had higher aromatase inhibitory activity than compound 1 (IC(50) = 2 +/- 0.5 microM versus 7 +/- 0.5 microM, K(i) = 1.5 microM versus 4.0 microM) and was a more potent type II ligand to the heme iron present in the cytochrome P450(arom) active site. Compound 2 inhibited aromatase activity in JEG-3 cells in a comparable manner to the inhibitor aminoglutethimide (AG) used clinically for the treatment of breast cancer. Additionally, compound 2 inhibited androstenedione-induced uterine hypertrophy in sexually immature mice (41% of uterine weight suppression for compound 2 versus 51% for AG). We conclude that the anti-aromatase activity of sesquiterpene lactones does not depend on the presence of the highly reactive alpha-methylene-gamma-lactone group, whereas their cytotoxicity does. These findings may facilitate the development of safer agents for breast cancer therapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0022-3565
pubmed:author
pubmed:issnType
Print
pubmed:volume
297
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1099-105
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11356934-Aminoglutethimide, pubmed-meshheading:11356934-Androstenedione, pubmed-meshheading:11356934-Animals, pubmed-meshheading:11356934-Antineoplastic Agents, pubmed-meshheading:11356934-Aromatase, pubmed-meshheading:11356934-Aromatase Inhibitors, pubmed-meshheading:11356934-Cell Line, pubmed-meshheading:11356934-Cell Survival, pubmed-meshheading:11356934-Choriocarcinoma, pubmed-meshheading:11356934-Dose-Response Relationship, Drug, pubmed-meshheading:11356934-Female, pubmed-meshheading:11356934-Humans, pubmed-meshheading:11356934-Hypertrophy, pubmed-meshheading:11356934-Lactones, pubmed-meshheading:11356934-Mice, pubmed-meshheading:11356934-Microsomes, pubmed-meshheading:11356934-Mitochondria, pubmed-meshheading:11356934-Organ Size, pubmed-meshheading:11356934-Placenta, pubmed-meshheading:11356934-Sesquiterpenes, pubmed-meshheading:11356934-Spectrum Analysis, pubmed-meshheading:11356934-Structure-Activity Relationship, pubmed-meshheading:11356934-Uterine Diseases, pubmed-meshheading:11356934-Uterine Neoplasms
pubmed:year
2001
pubmed:articleTitle
Aromatase inhibition by an 11,13-dihydroderivative of a sesquiterpene lactone.
pubmed:affiliation
Department of Clinical Biochemistry, Consejo Nacional de Investigaciones Científicas y Técnicas, Faculty of Chemical Sciences, National University of Córdoba, Córdoba, Argentina. javier.blanco@stjude.org
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't